Insulin Resistance presentations about Insulin Resistance EB with interest for Insulin Resistance Validating Insulin Resistance content Free registration form / enregistrement gratuit
1
2
  Franšais - August 16, 2011
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.

CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
 Presentation

"IDF Consensus on the Metabolic Syndrome: Definition and Treatment"

Dr. Sir George Alberti (biography)
English - 2005-04-14 - 38 minutes
(29 slides)

Summary :
The modern era of the "metabolic syndrome" began with the seminal work of Reaven and his Banting Lecture in 1988. He described the association of glucose intolerance, hypertension, dyslipidaemia and obesity and termed it Syndrome X with insulin resistance suggested as the unifying underlying aetiological factor. An explosion of studies and publications followed with the syndrome given a variety of names and a wide range of variables being added to the list of abnormalities. The metabolic syndrome has proved the most durable and popular of the names.

In 1999 WHO published a suggested definition with a sine qua non of glucose intolerance or insulin resistance together two or more of hypertension, central obesity and dyslipidaemia (Raised TG, lowered HDL-cholesterol. The Nation Cholesterol Education Program came out with its own definition (ATPIII) 2 years later with less primacy for glucose intolerance & different cutpoints for the variables. The European Study Group for Insulin Resistance also produced a variant of the WHO definition. In order to clarify the situation IDF held a Consensus meeting in 2004 to update the WHO definition and to see whether a single common clinically and epidemiologically useful definition could be agreed for use world-wide. It was agreed that insulin resistance although an important part of the syndrome could not be measured simply and reproducibly and should be included. It was also agreed that central obesity, particularly when associated with raised plasma triglycerides, was a sine qua non. There was however acceptance that waist circumference, as a measure of central adiposity, was ethnic-specific and that different cutpoints would be needed for different ethnic groups. The other agreed components were low HDL-cholesterol (gender specific), hypertension and fasting hyperglycaemia or previously diagnosed diabetes. The final conclusions of the group with regard to specific cutpoints will be presented.

Learning objectives :
After viewing this presentation the participant will be able to discuss:

- Different names and criteria used to describe the metabolic syndrome
- Conclusions from the 2004 IDF Consensus Meeting on the Metabolic Syndrome

   


  Login
  Username :
  Password :
   
  Lost your password?


  Search our website
  Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes.
 

  Social
  Let others know about this presentation.

 Del.icio.us
 Digg!



MULTILEARNING - MULTIWEBCAST - MULTIEPOSTER - MULTIEPORTAL

Copyright © 2002-2015 MULTILEARNING Group INC.. All rights reserved.  Disclaimer
Powered by Multiwebcast - webcast services


USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
insulin resistanceC-Reactive Protein (CRP)CRP, C-Reactive ProteinADHD ADDdiabetes insulin